Elex Biotech Awarded NIH Small Business Grant to Develop Drugs to Treat Heart Arrhythmias
Tuesday, November 11, 2014 - 7:50am
Portland, Oregon, November 7, 2014 — Elex Biotech, LLC, a biotech firm with ties to Portland State University (PSU), has received a two-year grant for over $1.4 Million from the National Institutes of Health. The grant will help support development of new drug compounds for the treatment of heart arrhythmias in catecholaminergic polymorphic ventricular tachycardia (CPVT), an often-fatal inherited disorder.
New faculty member Steve Reichow studies the form and function of membrane proteins, a class of proteins with potentially significant implications for our understanding of physiology and the targeted treatment of disease.